Categories: Artificial IntelligenceHealthTechTechnology
Manas AI is the AI-native biopharmaceutical company. We combine pioneering AI technology with the first principles of chemistry, physics and biology to transform the clinical pipeline from target to medicine.
Investors 1
Mentions in press and media 5
| Date | Title | Description |
| 26.09.2025 | Manas AI Secures $26M Seed Extension, Bolstering AI Drug Discovery | Manas AI, a leader in AI-driven drug discovery, announced a $26 million seed extension. This capital accelerates its mission. The company develops faster, more precise, and cost-efficient medicines. Ujjwal Singh now serves as Co-Founder and... |
| 23.09.2025 | Manas AI Raises $26M in Seed Extension | Manas AI, a NYC-based AI native drug discovery and development company, raised $26M in Seed extension funding.
Backers included The General Partnership, Wisdom Ventures, Blitzscaling Ventures, Westbound Equity Partners, Mosaic Ventures, and... |
| 03.02.2025 | This Startup Is Billionaire Reid Hoffman's Next Big Bet Hoffman sold LinkedIn, which he co-founded, to Microsoft for $26.2 billion in 2016. | LinkedIn co-founder Reid Hoffman became a billionaire when Microsoft bought LinkedIn in 2016 for $26.2 billion in cash, and he has also made his fortune on high-return investments in more than 80 tech startups, including Airbnb, Groupon, an... |
| - | Reid Hoffman enters ‘wondrous and terrifying’ world of health care with latest AI startup | Tech investor Reid Hoffman is tackling drug development with his new startup Manas AI, which he launched with oncologist Dr. Siddhartha Mukherjee this week.
Manas will use artificial intelligence to try and accelerate the drug discovery pro... |
| - | Manas AI | “Manas AI’s approach uses proprietary AI models, generative computational chemistry, and leading biology to reduce drug development timelines and costs, transforming cancer and rare disease treatments.” |
Reviews 0
